Altacor

About:

Altacor develops ophthalmic products for ophthalmologists and patients.

Website: http://www.altacor-pharma.com/

Twitter/X: AltacorEye

Top Investors: Beringea, Cambridge Angels group, NVM Private Equity, Enterprise Ventures, ProVen VCT

Description:

Altacor develops and brings to market specialist ophthalmic products designed for the needs of both ophthalmologists and patients. Altacor brings together skills in drug development with in-depth market knowledge and an understanding of the European regulatory environment, to create a portfolio of high quality, differentiated prescription medicines that set new standards in the sector. Altacor's pipeline includes products for dry-eye, glaucoma, glaucoma surgery and ocular surgery.

Total Funding Amount:

1.9M GBP

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Cambridgeshire, United Kingdom

Founded Date:

2005-01-01

Contact Email:

info(AT)altacor-pharma.com

Founders:

Francesca Crawford

Number of Employees:

11-50

Last Funding Date:

2011-02-09

IPO Status:

Private

Industries:

© 2025 bioDAO.ai